Scan to downloadONO PHARMACEUTICAL CO., LTD. (4528) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-10-29 | Earnings Release | Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2027 (IFRS) | |
| 2026-10-29 | — | 2nd Quarter of Fiscal Year 2026 (Ending March 31, 2027) (April 1, 2026 to September 30, 2026) Supplementary Materials (Consolidated IFRS) | |
| 2026-10-08 | — | Ono Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN | |
| 2026-07-31 | Earnings Release | Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2027 (IFRS) |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.